RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 15.3
(-1.29%)
EUR 15.3
(-1.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 162.47 Million EUR | -83.83% |
| 2022 | 963.25 Million EUR | 1.3% |
| 2021 | 950.92 Million EUR | 2.66% |
| 2020 | 926.29 Million EUR | 10.41% |
| 2019 | 838.99 Million EUR | 5.52% |
| 2018 | 795.13 Million EUR | -2.25% |
| 2017 | 813.41 Million EUR | 9.9% |
| 2016 | 740.12 Million EUR | 8.03% |
| 2015 | 685.13 Million EUR | -37.25% |
| 2014 | 1.09 Billion EUR | -46.76% |
| 2013 | 2.05 Billion EUR | 5.3% |
| 2012 | 1.94 Billion EUR | 12.1% |
| 2011 | 1.73 Billion EUR | 2.46% |
| 2010 | 1.69 Billion EUR | 9.9% |
| 2009 | 1.54 Billion EUR | 8.78% |
| 2008 | 1.41 Billion EUR | 160.0% |
| 2007 | -2.36 Billion EUR | -3.73% |
| 2006 | -2.27 Billion EUR | -40.72% |
| 2005 | -1.61 Billion EUR | -38.0% |
| 2004 | -1.17 Billion EUR | -295.49% |
| 2003 | 600.22 Million EUR | 9.06% |
| 2002 | 550.35 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | -22.9 Million EUR | 26.33% |
| 2024 Q1 | -31.08 Million EUR | 15.59% |
| 2023 Q4 | -36.82 Million EUR | -116.25% |
| 2023 Q1 | 235.02 Million EUR | -5.16% |
| 2023 Q3 | 226.63 Million EUR | -6.77% |
| 2023 FY | 155.72 Million EUR | -83.83% |
| 2023 Q2 | 243.08 Million EUR | 3.43% |
| 2022 Q1 | 237.16 Million EUR | -7.13% |
| 2022 Q2 | 241.85 Million EUR | 1.98% |
| 2022 FY | 963.25 Million EUR | 1.3% |
| 2022 Q3 | 236.41 Million EUR | -2.25% |
| 2022 Q4 | 247.82 Million EUR | 4.82% |
| 2021 Q2 | 233.3 Million EUR | 0.76% |
| 2021 Q3 | 230.66 Million EUR | -1.13% |
| 2021 Q4 | 255.38 Million EUR | 10.72% |
| 2021 Q1 | 231.53 Million EUR | -1.3% |
| 2021 FY | 950.92 Million EUR | 2.66% |
| 2020 FY | 926.29 Million EUR | 10.41% |
| 2020 Q3 | 229.19 Million EUR | -1.6% |
| 2020 Q4 | 234.57 Million EUR | 2.35% |
| 2020 Q2 | 232.92 Million EUR | 1.4% |
| 2020 Q1 | 229.71 Million EUR | 7.18% |
| 2019 Q1 | 216.92 Million EUR | 6.81% |
| 2019 FY | 838.99 Million EUR | 5.52% |
| 2019 Q2 | 204.49 Million EUR | -5.73% |
| 2019 Q3 | 203.26 Million EUR | -0.6% |
| 2019 Q4 | 214.33 Million EUR | 5.45% |
| 2018 Q2 | 209.17 Million EUR | 1.65% |
| 2018 Q3 | 176.97 Million EUR | -15.39% |
| 2018 Q4 | 203.08 Million EUR | 14.75% |
| 2018 Q1 | 205.77 Million EUR | -1.29% |
| 2018 FY | 795.13 Million EUR | -2.25% |
| 2017 Q3 | 204.83 Million EUR | 1.13% |
| 2017 FY | 813.41 Million EUR | 9.9% |
| 2017 Q4 | 208.46 Million EUR | 1.77% |
| 2017 Q2 | 202.54 Million EUR | 0.17% |
| 2017 Q1 | 202.2 Million EUR | 2.16% |
| 2016 Q1 | 155.64 Million EUR | -7.49% |
| 2016 Q2 | 193.48 Million EUR | 24.32% |
| 2016 Q3 | 197.2 Million EUR | 1.92% |
| 2016 Q4 | 197.93 Million EUR | 0.37% |
| 2016 FY | 740.12 Million EUR | 8.03% |
| 2015 Q2 | 182.09 Million EUR | 14.05% |
| 2015 Q1 | 159.65 Million EUR | -19.69% |
| 2015 FY | 685.13 Million EUR | -37.25% |
| 2015 Q4 | 168.24 Million EUR | -5.1% |
| 2015 Q3 | 177.28 Million EUR | -2.64% |
| 2014 Q4 | 198.79 Million EUR | 5.26% |
| 2014 Q2 | 295.68 Million EUR | -28.03% |
| 2014 FY | 1.09 Billion EUR | -46.76% |
| 2014 Q3 | 188.86 Million EUR | -36.13% |
| 2014 Q1 | 410.81 Million EUR | -20.02% |
| 2013 Q3 | 515.25 Million EUR | -0.09% |
| 2013 Q4 | 513.68 Million EUR | -0.31% |
| 2013 FY | 2.05 Billion EUR | 5.3% |
| 2013 Q2 | 515.74 Million EUR | 0.5% |
| 2013 Q1 | 513.19 Million EUR | 3.5% |
| 2012 Q3 | 502.66 Million EUR | 1.9% |
| 2012 Q2 | 493.28 Million EUR | 8.24% |
| 2012 Q1 | 455.72 Million EUR | 4.7% |
| 2012 FY | 1.94 Billion EUR | 12.1% |
| 2012 Q4 | 495.85 Million EUR | -1.35% |
| 2011 Q2 | 433.81 Million EUR | 1.12% |
| 2011 Q1 | 428.98 Million EUR | 0.8% |
| 2011 Q3 | 439.28 Million EUR | 1.26% |
| 2011 Q4 | 435.25 Million EUR | -0.92% |
| 2011 FY | 1.73 Billion EUR | 2.46% |
| 2010 Q1 | 416.29 Million EUR | 6.05% |
| 2010 FY | 1.69 Billion EUR | 9.9% |
| 2010 Q4 | 425.59 Million EUR | -0.47% |
| 2010 Q3 | 427.61 Million EUR | 0.35% |
| 2010 Q2 | 426.12 Million EUR | 2.36% |
| 2009 FY | 1.54 Billion EUR | 8.78% |
| 2009 Q4 | 392.55 Million EUR | 0.55% |
| 2009 Q3 | 390.4 Million EUR | 0.84% |
| 2009 Q2 | 387.14 Million EUR | 3.85% |
| 2009 Q1 | 372.78 Million EUR | 0.0% |
| 2008 FY | 1.41 Billion EUR | 160.0% |
| 2007 FY | -2.36 Billion EUR | -3.73% |
| 2006 FY | -2.27 Billion EUR | -40.72% |
| 2005 FY | -1.61 Billion EUR | -38.0% |
| 2004 FY | -1.17 Billion EUR | -295.49% |
| 2003 FY | 600.22 Million EUR | 9.06% |
| 2002 FY | 550.35 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 3.55 Billion EUR | 95.43% |
| Fresenius SE & Co. KGaA | 3.91 Billion EUR | 95.85% |
| LIMES Schlosskliniken AG | 11.2 Million EUR | -1349.943% |
| M1 Kliniken AG | 16.77 Million EUR | -868.647% |
| Maternus-Kliniken Aktiengesellschaft | 17.48 Million EUR | -829.39% |
| MEDICLIN Aktiengesellschaft | 70.03 Million EUR | -131.994% |
| VITA 34 AG | 31.36 Million EUR | -418.033% |